Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients
Authors
Keywords
-
Journal
Biomed Research International
Volume 2013, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2013-11-22
DOI
10.1155/2013/956878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
- (2013) Fabio Morandi et al. Journal of Neuroimmune Pharmacology
- Bone Marrow-Infiltrating Human Neuroblastoma Cells Express High Levels of Calprotectin and HLA-G Proteins
- (2012) Fabio Morandi et al. PLoS One
- Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma
- (2012) Maria Valeria Corrias et al. OncoTargets and Therapy
- Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors
- (2012) Simron Singh et al. Expert Review of Gastroenterology & Hepatology
- Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
- (2011) Fabio Morandi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
- (2011) Madhu Gowda et al. Journal of Translational Medicine
- Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer
- (2011) Mathilde Allard et al. PLoS One
- Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels
- (2010) Donatella Granchi et al. BONE
- Chromogranin A as a Crucial Factor in the Sorting of Peptide Hormones to Secretory Granules
- (2010) Salah Elias et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- HLA-F is a surface marker on activated lymphocytes
- (2010) Ni Lee et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry
- (2010) Riccardo Haupt et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
- (2010) Ruth Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- This Week in the Journal
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- HLA-G and HLA-E in patients with juvenile idiopathic arthritis
- (2010) I. Prigione et al. RHEUMATOLOGY
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma WithoutMYCNGene Amplification
- (2009) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
- (2008) B De Bernardi et al. BRITISH JOURNAL OF CANCER
- Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule
- (2008) A Gregorio et al. HISTOPATHOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now